{"name":"Karyopharm Therapeutics Inc","slug":"karyopharm-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"KCP-330","genericName":"KCP-330","slug":"kcp-330","indication":"Other","status":"phase_1"},{"name":"Matching placebo for selinexor","genericName":"Matching placebo for selinexor","slug":"matching-placebo-for-selinexor","indication":"Other","status":"phase_3"}]}],"pipeline":[{"name":"KCP-330","genericName":"KCP-330","slug":"kcp-330","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Matching placebo for selinexor","genericName":"Matching placebo for selinexor","slug":"matching-placebo-for-selinexor","phase":"phase_3","mechanism":"This is a matching placebo control used in clinical trials for selinexor, not an active drug.","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE5GaEhmRmNGTDFZMTdwT24xRk42NVJGOHk0TXF6UUtVREo2TXQ5ZVRvOFh1ckxzRkFZQWJaWmlSdWw4Y0c2UWlWa0Z3eVhsUDFBc29iYXhCaUk0NDZpbDNZ?oc=5","date":"2026-04-02","type":"pipeline","source":"ChartMill","summary":"KPTI Stock Price, Quote & Chart | KARYOPHARM THERAPEUTICS INC (NASDAQ:KPTI) - ChartMill","headline":"KPTI Stock Price, Quote & Chart | KARYOPHARM THERAPEUTICS INC (NASDAQ:KPTI)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxPWXltbXltM2tBbm1QLUpWZmpQYXB2LS0wb1RhXzlwRl9YY2ZPTnpidGpOXzI2R2FNRk5MdDE1RWJtTlBhM3dDb3dwdWR5UW5RbERUMjlOTU9oQ0E5eHdmRnRkOEd0Ymx0RTF4R21IWkt2cFd0cmZDVmk4VkNmY0ViT1Uwby1WMzU1SVpyYW5oakFSdTRlLWtJQWMzaUx6UFloNzc5WDdzM25scmlQbVYwZTVPREZnQlBjcFNRekVn?oc=5","date":"2026-03-24","type":"pipeline","source":"prnewswire.com","summary":"Karyopharm Announces $30 Million Private Placement with RA Capital - prnewswire.com","headline":"Karyopharm Announces $30 Million Private Placement with RA Capital","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1AFBVV95cUxQdlVKZzVGZUVsM2Y5LUM2YjZQRkRzOGZGVG1XQzFIV1cyVFVjZXdfeW9WblN3RFBSMEpOUDdXNndaZ3VSYTdxeGM3VHJTTUtvR2w1TG9yck1OSURPV1BMZ3N0eW5BNWg3WTlDMTRSSTdSeXMyYUF5NFVSUktPTVhBN1BudjlhN2tHdm5QS05LWE05R1dTeWViTFNNUVNYbzRjQ0RDcEtBaWJfTmNDRnRnZUhTbUZFWUI0N0RNcTBScXVMeTNSWFlyc1kxS2t6SkFoSnp2Wg?oc=5","date":"2026-03-02","type":"pipeline","source":"prnewswire.com","summary":"Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - prnewswire.com","headline":"Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6AFBVV95cUxQbFVpaDVZRzFmdm9VamtFdEE5dFpIbkhqMFNvZXZIcVhNb2ZLMUxId1U1ZTVTcjN3RWpwSC1peVhuTExNYkFodnlfVzlMaklRM1FoblY5UVhsR0lRblZVaDFmT00tUDItV0Fwb1VValcxZktrSmhOZ1BsQ1h1SFA1Y0VsaGdBM2ZWN1BMUGNkY1dfZWoxVjl6WkZITXVzbGtMRmQzbVlIN1JXNjl1VkF5eWF4ZjBmZEpWZkJsVFFDa01zV1piQmxjZzdhZURyQkNwZXVmWHNfYU1PY21Pc3k2MlJ0NnVNWHZp?oc=5","date":"2026-02-12","type":"earnings","source":"Karyopharm","summary":"Karyopharm Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Company Progress - Karyopharm","headline":"Karyopharm Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Company Progress","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0wFBVV95cUxNZ2lic1pVeGY0U0JSYjU5RE44UmZzemN1UWlFckZQYlpmckU0Zml5NXpDaWJPYVI5S3ZpLVh3UExRcldvaU5GLThqMHZHajlHWVl3TG9sZEVKYS1HNVB3YnBOMzF6amNrbC1YUVpoVlhIVVdZOTlNcWhFTk8tVklFNXhZbU5HSU5pYVI3MlN3Z3ZYeWR1M3RzOTBmMVNzMExMYUxHa3JsOXAzOVZJaUl6LWduTDdzQXVSYkUtelliZFpUODdwMjIwWXhXeU1TM21kMG9r?oc=5","date":"2026-02-05","type":"earnings","source":"Karyopharm","summary":"Karyopharm to Report Fourth Quarter and Full Year 2025 Financial Results on February 12, 2026 - Karyopharm","headline":"Karyopharm to Report Fourth Quarter and Full Year 2025 Financial Results on February 12, 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxOMXNtSHAyRUpKS1ZTcHRQWlR5eW5yY1ZsQnVuTUFSY0xlUHZfNUp3eVFOMmphMkNwV3FyT2o4WFUxOGNfV1BSZUdveHdVcWRKZmRvNnJtVmsxMnN5WGNTSEVLODhGeG01aEd0OUxkbzhjaW9yMFhXWEdZZjFtRkk0akRnbEd6TkFzTEhYRl9MaXk1alY2aTJiRjNnRHp3SlpITU5jZ1ZKRQ?oc=5","date":"2025-12-08","type":"pipeline","source":"Karyopharm","summary":"Karyopharm to Participate in Baird's Biotech Discovery Series - Karyopharm","headline":"Karyopharm to Participate in Baird's Biotech Discovery Series","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxPeEg5X21IS2FLcjVsdG1hRTNVX3ViWDNXUjF5YW9xRHlEN3NSQlVZREtTQzhWS3NNenB0VHZoMmxIekZlQ3UxQmMyNEtNVWJObERodkpsdHNSeE4zZjZLTGhVcVA4UnRSMzNiWjNJZUdJNHlGd0g3TC1TQl9lM2l2bTBVdFphRmFza1NQaVlMeXBqSWdRV1VsbGJsWDVyTHp4TUp3RlgyWFpodzdsbWRfV1U0SjhPZEJpbHBVZDN3?oc=5","date":"2025-10-27","type":"earnings","source":"Karyopharm","summary":"Karyopharm to Report Third Quarter 2025 Financial Results on November 3, 2025 - Karyopharm","headline":"Karyopharm to Report Third Quarter 2025 Financial Results on November 3, 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2gJBVV95cUxQelZqMlBKS0FWUzFERjFkdDNBNUx4VUtJZHZUVGxnTVZMTXVod1NfZnM5TVd5UlgtVTZIcG0xdmtpV1JNMUktdmR4MDBMNmdYR0VFeHNSYXdiUkVIUWsxNll4MGpjMVo0X0pFRnZHa0ppUUx3T3ZQMFB2MnNUbXc0QUszNmtTM3RXZ2k5dlhiRlVRbHZXV3FsWVFKdUkzQmJUajhiSU5VdGM4VUpRd21mZDJXQzZFX1J5OTdCZHRZOTVnMzJrNDg1cUFmcW5DWDM4THNPNk03cW1VV3U1QjlLdU40bzFpS05wX05VM2VDZmdxVV8yX3pYRFBuYlkzZXlvNDRlY0YwNlM4d3BqWXZKc2tDLXNpb0IyLUNYY3JSMTFyaFBGa1dVbTBVbDVaTWdhZmkwWi13SEVKTWl0Sm16MXhkZHozY3NxZndLRXJZNUp2cUpnOUZKN0J3?oc=5","date":"2025-10-08","type":"trial","source":"Karyopharm","summary":"Karyopharm Announces Strategic Financing Transactions to Support Growth; Extends Cash Runway Into Second Quarter of 2026, Beyond Expected Top-Line Readout of Phase 3 SENTRY Trial in Myelofibrosis - Ka","headline":"Karyopharm Announces Strategic Financing Transactions to Support Growth; Extends Cash Runway Into Second Quarter of 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5gFBVV95cUxQbEZxanhLRFpQeEJ1OXFHU1VsZ2lCZXdRQWZNT0xBTzFGRFc2VTN2VWUzMHVudW5kbjNFVkFkNXkzWDdwUENhYTNIazhwVFBwY2JOOU1HWllvQ1dGbkJHTlNnZk1YYVdQZ1Ytd0JnR3RxYU9IWjZhZ3lPMHJabzdLeUlZYTFkUWY2MjhqU3REOEJ0S0Z1a3ZGcHF0emlaXzl6Q3JEWWhaRlNqS2x5TFJoMl9Jc3NTYmVkQ0JQaU5FX2xOeDc1M0VTUk4yZ1hLV2NBVUpTcGlBSXR6WVRndVBxb0NIQWRXUQ?oc=5","date":"2025-08-11","type":"earnings","source":"prnewswire.com","summary":"Karyopharm Reports Second Quarter 2025 Financial Results and Highlights Recent Company Progress - prnewswire.com","headline":"Karyopharm Reports Second Quarter 2025 Financial Results and Highlights Recent Company Progress","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxPMVRhanRzOFdqV1NCRnJfdlRCLV85aWhnOGNPaWxzSVNJT1JfNmp3OW1ObXN3RVVTcWVUcXd6enJwMGlLbDEyRnlnZGpYTmlIblA5em5aajJzYTdBaEhZRHFUaWlFLWJKaVNPUEJBMUVZSnA3RFlWUE4wV291QXdYUnNERkZCRGpiSEJTZzZQMENvWXpmQ3BONldDclAxUGVIYkdfRjc2VXZaWTVkck9laHV5WlphTU1v?oc=5","date":"2025-05-08","type":"earnings","source":"Karyopharm","summary":"Karyopharm to Report First Quarter 2025 Financial Results on May 12, 2025 - Karyopharm","headline":"Karyopharm to Report First Quarter 2025 Financial Results on May 12, 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxOZWwxWU9aM09IMlZ4ZjJJMnRxYWEyQTdWbUFFNkNIcTE2VkQ5c2FSUmYyTkZiWmtaN3Iybk5lck5KanpvWTZCLUZRUUd6UmpVeEdhZlFzUVo5eEFsMFctd1c2dHBhYkUzQTgwRy05YVhkUGFpRnRDUnd4cTByV2NUWlJwUjhTcTVXYWVvZmdiRERDdnllOXVhVXJaOVJTbjVOWVFYV041alp2bzkwQ0lJ?oc=5","date":"2024-12-03","type":"trial","source":"Karyopharm","summary":"Karyopharm Therapeutics Provides Endometrial Cancer Program Update - Karyopharm","headline":"Karyopharm Therapeutics Provides Endometrial Cancer Program Update","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxOYThOQUU4MTJ2aW5KS3RHSFo2bmZHaVpfYlZlblhXU3B4Yk5UQ0h2dUhMS3dxek9QRjNoYkFQamtqMU5hRG9iSFAwZlJCNmptd1J2UngzWVp1ZTZmUWZ6T1R0SnRVQUtkZEE1VUF4aG9wdDhSbUdxUjU1c2ducnVaNFYzNTh1amZLRWtGenhXdk9LRjJKdE8xa1htdEZ3QTRxZnduSEc4Z18tVHRZbmFDSUZIUQ?oc=5","date":"2024-01-03","type":"pipeline","source":"Karyopharm","summary":"Karyopharm to Present at 42nd Annual J.P. Morgan Healthcare Conference - Karyopharm","headline":"Karyopharm to Present at 42nd Annual J.P. Morgan Healthcare Conference","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_1":1,"phase_3":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}